APA (7th ed.) Citation

J, v. D., C, P., BBM, S., N, M., N, v. D., G, M., . . . MS, v. d. H. (2023). High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: The phase 1B NABUCCO trial. Nature medicine, 29(3), 588. https://doi.org/10.1038/s41591-022-02199-y

Chicago Style (17th ed.) Citation

J, van Dorp, et al. "High- or Low-dose Preoperative Ipilimumab Plus Nivolumab in Stage III Urothelial Cancer: The Phase 1B NABUCCO Trial." Nature Medicine 29, no. 3 (2023): 588. https://doi.org/10.1038/s41591-022-02199-y.

MLA (9th ed.) Citation

J, van Dorp, et al. "High- or Low-dose Preoperative Ipilimumab Plus Nivolumab in Stage III Urothelial Cancer: The Phase 1B NABUCCO Trial." Nature Medicine, vol. 29, no. 3, 2023, p. 588, https://doi.org/10.1038/s41591-022-02199-y.